Vesper Bio

Copenhagen, Denmark

Vesper Bio is a clinical-stage biotechnology company.

$873K raised

Jan 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vesper Bio raised?

Vesper Bio has raised $873K in total funding. The most recent round was Grant. The last funding was announced in January 2024.

Who are Vesper Bio's investors?

Vesper Bio's investors include Michael J. Fox Foundation.

Where is Vesper Bio headquartered?

Vesper Bio is headquartered in Copenhagen, Denmark.

What does Vesper Bio do?

Vesper Bio is a clinical-stage biotechnology company.

What stage is Vesper Bio at?

Vesper Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 23, 2024.

MLA

"Vesper Bio — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/vesper-bio. Accessed July 2, 2026.

APA

VCBacked. (2024). Vesper Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vesper-bio

Wikipedia (cite web)

{{cite web |title=Vesper Bio — Funding & Investors |url=https://www.vcbacked.co/company/vesper-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 23, 2024.